EBITDA: Income before interest, taxes, depreciation and amortization.
NanoViricides, Inc. (NNVC) had EBITDA of $-7.76M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-8.29M |
|
-- |
|
-- |
|
$8.52M |
|
$-8.52M |
|
$0.22M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.52M |
|
|
EBITDA |
$-7.76M |
11.87M |
|
11.87M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$4.97M |
|
$7.51M |
|
$7.85M |
|
$12.82M |
|
$1.36M |
|
-- |
|
-- |
|
$1.36M |
|
$11.46M |
|
$11.14M |
|
$11.46M |
|
13.14M |
|
| Cash Flow Statement Financials | |
$-6.32M |
|
$-0.16M |
|
$3.12M |
|
$8.15M |
|
$4.80M |
|
$-3.35M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-72.35% |
|
-74.46% |
|
-64.68% |
|
-72.35% |
|
$0.87 |
|
$-0.55 |
|
$-0.53 |
|